New Zealand markets open in 8 hours 36 minutes

Zoetis Inc. (ZTS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
200.33-1.63 (-0.81%)
At close: 04:04PM EST
200.33 0.00 (0.00%)
After hours: 07:37PM EST
Full screen
Trade prices are not sourced from all markets
Previous close201.96
Bid198.00 x 900
Ask200.25 x 1000
Day's range200.28 - 203.71
52-week range141.41 - 249.27
Avg. volume1,780,338
Market cap94.781B
Beta (5Y monthly)0.66
PE ratio (TTM)48.28
EPS (TTM)4.15
Earnings date15 Feb 2022
Forward dividend & yield1.30 (0.65%)
Ex-dividend date19 Jan 2022
1y target est248.83
  • Motley Fool

    2 Stocks That Could Turn $250,000 Into $1,000,000 By 2032

    Let's look at two excellent companies that could turn $250,000 into $1,000,000 -- that's a compound annual growth rate of 14.87% -- in the next 10 years: Zoetis (NYSE: ZTS) and Spotify (NYSE: SPOT). Zoetis is one of the leading animal health companies in the world. Zoetis boasts 13 products that generate $100 million or more in annual revenue, and its financial results continue to impress.

  • Business Wire

    Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats

    PARSIPPANY, N.J., January 13, 2022--Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Solensia™ to control the pain of osteoarthritis (OA) in cats.

  • Motley Fool

    Why Zoetis Stock Gained 47% in 2021

    Shares of Zoetis (NYSE: ZTS) had a strong 2021 as the animal health company posted solid growth throughout the year and consistently raised its guidance. Zoetis shares slumped through the first two months of the year as a solid fourth-quarter 2020 earnings report wasn't enough to give the stock a boost.